GleamWall
中文EN

SMMT Summit Therapeutics Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1599298 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY9.6%
TTM EPS YoY15.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-220.0%
ROA-174.5%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets18.5%
Debt / equity0.00x
Current ratio5.99x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.63x
Accruals ratio-64.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue—$0
R&D expense$537.67M$150.78M
SG&A expense$556.75M$60.21M
Operating income—-$226.00M
Interest expense$0$8.69M
Pretax income-$1.08B-$221.31M
Income tax$0$0
Net income-$1.08B-$221.31M
EBITDA—-$225.91M
EPS (basic)-1.44-0.31
EPS (diluted)-1.44-0.31
Weighted avg. shares (diluted)747.70M718.54M
Balance sheet
Cash & equivalents$225.27M$105.19M
Short-term investments$488.18M$307.49M
Current assets$720.30M$423.75M
PP&E, net$1.06M$254,000
Goodwill$2.00M$1.86M
Intangibles—$0
Total assets$751.18M$435.56M
Current liabilities$72.99M$41.73M
Total liabilities$92.32M$46.81M
Shareholders' equity$658.86M$388.75M
Shares outstanding775.37M737.63M
Cash flow statement
Operating cash flow-$322.93M-$142.11M
Capital expenditure$657,000$139,000
Free cash flow-$323.59M-$142.25M
Investing cash flow-$174.31M-$205.34M
Financing cash flow$617.53M$381.23M
Depreciation & amortization$146,000$89,000
Stock-based compensation$732.42M$50.98M

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.